×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CYCN – cyclerion therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CYCN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/2
03:41 pm
cycn
Cyclerion Therapeutics (NASDAQ:CYCN) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Cyclerion Therapeutics (NASDAQ:CYCN) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
11/10
10:26 am
cycn
EXCLUSIVE: Cycurion Wins $1 Million+ Contract To Modernize Federal Emergency Warning Network [Yahoo! Finance]
Medium
Report
EXCLUSIVE: Cycurion Wins $1 Million+ Contract To Modernize Federal Emergency Warning Network [Yahoo! Finance]
9/24
01:09 pm
cycn
Cyclerion Therapeutics, Inc. (CYCN) Discusses On Pioneering A New Era In Neuropsychiatric Therapies Call (Transcript) [Seeking Alpha]
Low
Report
Cyclerion Therapeutics, Inc. (CYCN) Discusses On Pioneering A New Era In Neuropsychiatric Therapies Call (Transcript) [Seeking Alpha]
9/24
12:56 pm
cycn
Cyclerion Therapeutics, Inc. - Pre Recorded Special Call [Seeking Alpha]
Low
Report
Cyclerion Therapeutics, Inc. - Pre Recorded Special Call [Seeking Alpha]
9/23
04:18 pm
cycn
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company [Yahoo! Finance]
High
Report
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company [Yahoo! Finance]
9/23
04:01 pm
cycn
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
Medium
Report
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/1
05:13 pm
cycn
Form 8-K Cyclerion Therapeutics, For: Dec 01
Low
Report
Form 8-K Cyclerion Therapeutics, For: Dec 01
11/12
04:31 pm
cycn
Form 10-Q Cyclerion Therapeutics, For: Sep 30
Medium
Report
Form 10-Q Cyclerion Therapeutics, For: Sep 30
11/12
04:16 pm
cycn
Form 10-K/A Cyclerion Therapeutics, For: Dec 31
Low
Report
Form 10-K/A Cyclerion Therapeutics, For: Dec 31
10/17
04:05 pm
cycn
Form SCHEDULE 13G Cyclerion Therapeutics, Filed by: J. WOOD CAPITAL ADVISORS LLC
Low
Report
Form SCHEDULE 13G Cyclerion Therapeutics, Filed by: J. WOOD CAPITAL ADVISORS LLC
9/23
04:15 pm
cycn
Form 8-K Cyclerion Therapeutics, For: Sep 19
High
Report
Form 8-K Cyclerion Therapeutics, For: Sep 19
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
1/13
Form 8-K Cyclerion Therapeutics, For: Jan 13
9.3%
4/2 Form 4 Cyclerion Therapeutics, For: Mar 31 Filed by: Hecht Peter M 7.0%
12/27 Form SC 13G Cyclerion Therapeutics, Filed by: EcoR1 Capital, LLC 6.7%
3/12 Form 10-K Cyclerion Therapeutics, For: Dec 31 6.4%
6/17 Form SC 13G Cyclerion Therapeutics, Filed by: Camber Capital Management LP 5.0%
2/25 Form 4 Cyclerion Therapeutics, For: Feb 21 Filed by: Huyett William 3.2%
12/13 Cyclerion Therapeutics, Inc. (CYCN) Is Burning These Hedge Funds [Yahoo! Finance News] 3.2%
2/3 Form SC 13G Cyclerion Therapeutics, Filed by: Artal International S.C.A. 3.0%
8/12 Form 10-Q Cyclerion Therapeutics, For: Jun 30 2.9%
5/9 Cyclerion Therapeutics: This Spinoff Has Multiple Readouts Coming Up, Concerns Remain [Seeking Alpha] 2.5%
4/2 Form 4 Cyclerion Therapeutics, For: Mar 31 Filed by: Hecht Peter M 7.0%
12/27 Form SC 13G Cyclerion Therapeutics, Filed by: EcoR1 Capital, LLC 6.7%
3/12 Form 10-K Cyclerion Therapeutics, For: Dec 31 6.4%
6/17 Form SC 13G Cyclerion Therapeutics, Filed by: Camber Capital Management LP 5.0%
2/25 Form 4 Cyclerion Therapeutics, For: Feb 21 Filed by: Huyett William 3.2%
12/13 Cyclerion Therapeutics, Inc. (CYCN) Is Burning These Hedge Funds [Yahoo! Finance News] 3.2%
2/3 Form SC 13G Cyclerion Therapeutics, Filed by: Artal International S.C.A. 3.0%
8/12 Form 10-Q Cyclerion Therapeutics, For: Jun 30 2.9%
5/9 Cyclerion Therapeutics: This Spinoff Has Multiple Readouts Coming Up, Concerns Remain [Seeking Alpha] 2.5%
TOP News Decliners
6/3
Cyclerion Therapeutics Inc (NASDAQ: CYCN) is now covered by analysts at Credit Suisse Group AG. They set a "neutral" rating on the stock.
-18.7%
3/5 Form 8-K Cyclerion Therapeutics, For: Feb 28 -12.0%
5/13 Cyclerion Therapeutics Provides a Corporate and Pipeline Overview as a Newly Launched Public Biopharmaceutical Company -9.4%
6/4 Form 4 Cyclerion Therapeutics, For: Jun 01 Filed by: CONRADES GEORGE H -6.6%
12/31 Form 4 Cyclerion Therapeutics, For: Dec 27 Filed by: Currie Mark G -5.5%
8/12 Cyclerion Therapeutics Reports Second Quarter 2019 Financial Results and Progress on Four Clinical Studies with Data Readouts Anticipated in the Next 12 Months -5.5%
11/27 Cyclerion to Present at the Evercore ISI 2nd Annual HealthCONx Conference -4.8%
9/20 Form 4/A Cyclerion Therapeutics, For: Apr 01 Filed by: Huyett William -3.5%
10/8 Cyclerion Therapeutics and Collaborators to Present New Research on the Sickle Cell Disease Patient Journey at Upcoming Medical Meetings -3.1%
2/7 Form SC 13G Cyclerion Therapeutics, Filed by: FMR LLC -2.9%
3/5 Form 8-K Cyclerion Therapeutics, For: Feb 28 -12.0%
5/13 Cyclerion Therapeutics Provides a Corporate and Pipeline Overview as a Newly Launched Public Biopharmaceutical Company -9.4%
6/4 Form 4 Cyclerion Therapeutics, For: Jun 01 Filed by: CONRADES GEORGE H -6.6%
12/31 Form 4 Cyclerion Therapeutics, For: Dec 27 Filed by: Currie Mark G -5.5%
8/12 Cyclerion Therapeutics Reports Second Quarter 2019 Financial Results and Progress on Four Clinical Studies with Data Readouts Anticipated in the Next 12 Months -5.5%
11/27 Cyclerion to Present at the Evercore ISI 2nd Annual HealthCONx Conference -4.8%
9/20 Form 4/A Cyclerion Therapeutics, For: Apr 01 Filed by: Huyett William -3.5%
10/8 Cyclerion Therapeutics and Collaborators to Present New Research on the Sickle Cell Disease Patient Journey at Upcoming Medical Meetings -3.1%
2/7 Form SC 13G Cyclerion Therapeutics, Filed by: FMR LLC -2.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: